MEDICAL REGULATIONS 11 Edition - FIVB
MEDICAL REGULATIONS 11 Edition - FIVB
MEDICAL REGULATIONS 11 Edition - FIVB
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>FIVB</strong> Medical Regulations – <strong>11</strong>th <strong>Edition</strong><br />
(Presence of a Prohibited Substance or its Metabolites or Markers). In<br />
circumstances where the Athlete (or the Athlete's team as may be<br />
provided in the rules of the <strong>FIVB</strong>) has been removed from a<br />
Competition based on a violation of Article 2.1 and the subsequent B<br />
Sample analysis does not confirm the A Sample finding, if, without<br />
otherwise affecting the Competition, it is still possible for the Athlete or<br />
team to be reinserted, the Athlete or team may continue to take part in<br />
the Competition.<br />
7.7 Retirement from Sport<br />
If an Athlete or other Person retires while a results management process is<br />
underway, the <strong>FIVB</strong> retains jurisdiction to complete its results management<br />
process. If an Athlete or other Person retires before any results management<br />
process has begun and the <strong>FIVB</strong> would have had results management<br />
jurisdiction over the Athlete or other Person at the time the Athlete or other<br />
Person committed an anti-doping rule violation, the <strong>FIVB</strong> has jurisdiction to<br />
conduct results management.<br />
ARTICLE 8<br />
RIGHT TO A FAIR HEARING<br />
8.1 Hearings arising out of <strong>FIVB</strong> Testing or Tests at International<br />
Events<br />
8.1.1 When it appears, following the Results Management process<br />
described in Article 7, that these Anti-Doping Rules have been violated<br />
in connection with <strong>FIVB</strong> Testing or Testing at an International Event<br />
then the case shall be assigned to the <strong>FIVB</strong> Doping Hearing Panel for<br />
adjudication.<br />
8.1.2 An <strong>FIVB</strong> Anti-Doping Hearing Panel with three members<br />
shall be appointed to hear each case. The President of the <strong>FIVB</strong><br />
Disciplinary Commission shall appoint two members from the <strong>FIVB</strong><br />
Disciplinary Commission (which may include the Chair). One of these<br />
members shall chair the panel. The President of the <strong>FIVB</strong> Medical<br />
Commission shall appoint a physician from the <strong>FIVB</strong> Medical<br />
Commission as the third member. The appointed members shall have<br />
had no prior involvement with the case and shall not have the same<br />
nationality as the Athlete or other Person alleged to have violated these<br />
Anti-Doping Rules.<br />
8.1.3 Hearings pursuant to this Article shall be completed<br />
expeditiously following the completion of the results management<br />
process described in Article 7. Hearings held in connection with Events<br />
may be conducted on an expedited basis.<br />
8.1.4 The National Federation of the Athlete or other Person<br />
alleged to have violated these Anti-Doping Rules may attend the<br />
hearing as an observer.<br />
8.1.5 The <strong>FIVB</strong> shall keep WADA fully apprised as to the status of<br />
pending cases and the result of all hearings.<br />
- 18 -